医学研究与教育 ›› 2014, Vol. 31 ›› Issue (3): 66-71.DOI: 10.3969/j.issn.1674-490X.2014.03.018

• 综述 • 上一篇    下一篇

中医药治疗心血瘀阻型冠心病心绞痛的临床研究进展

崔番瑜,杨少琴   

  1. 中关村医院,北京,100000
  • 出版日期:2014-06-25 发布日期:2014-06-25
  • 基金资助:
    北京市海淀区公共委“人才折子”工程项目

Advances on clinical research of blood stasis coronary heart disease angina pectoris treated with Chinese medicine

CUI Fanyu,YANG Shaoqin   

  • Online:2014-06-25 Published:2014-06-25

摘要: 冠心病心绞痛是临床常见病,其发病率、致残率和病死率均较高,严重影响着人类的健康,尤其是40岁以上的脑力劳动者更是高危人群。一直以来,很多中医学者都致力于冠心病心绞痛的预防和治疗研究,并研制出了众多新型中成药。选取心血瘀阻型冠心病心绞痛的临床研究资料,着重综述了近几年来对于冠心病心绞痛心血瘀阻证的临床用药疗效以及新型中成药的研发现状。

关键词: 冠心病, 心绞痛, 心血瘀阻证, 中成药, 新剂型

Abstract: Coronary heart disease (CHD) angina pectoris is a common clinical disease with high rates of incidence, morbidity and mortality, which has a serious inlfuence on human health, especially on the mental workers aged more than 40-year-old who are in high risk. Many Chinese medical scholars were committed to the research of prevention and treatment for CHD angina pectoris all along, and they developed a number of new Chinese medicine. In this paper, the clinical research data of blood stasis CHD angina pectoris were selected, and it emphatically summarized the clinical drug efifcacy of blood stasis type of angina pectoris syndrome in recent years, as well as the research and development (R&D) status of new Chinese medicine.

Key words: coronary heart disease, angina pectoris, blood stagnation syndrome, Chinese medicine, new formulations

中图分类号: